DOYLE JANEEN NOEL (Chief Corp. & Bus. Dev. Ofcr) sold 5.1% of their position (4.06K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $56.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2026ACC: 0002069239-26-000005
Officer· Chief Corp. & Bus. Dev. Ofcr
Since May 2025
-4.06K
Net shares
Net seller
$56.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.06K
Price / share
$14.03
Trade value
$56.94K
% of position
5.1%
6/2/2026
80K→75.94K
Total
Net shares
−4.06K
Net value
-$56.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | S · Sale | −4.06K | $14.03 | $56.94K | 5.1% | 80K | 75.94K |
| Total | −4.06K | -$56.94K | ||||||
Derivative Transactions0
No derivative transactions reported